The Toronto-Dominion Bank
TD
Bank of Montreal
BMO
Royal Bank of Canada
RY
Bank of Nova Scotia
BNS
Canadian Imperial Bank of Commerce
CM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 90.19%-1.02M | -79.25%894K | -206.61%-2.13M | 61.69%-1.38M | 392.01%5.38M | -333.02%-10.37M | 181.34%4.31M | 23.68%-696K | 67.19%-3.6M | 21.65%-1.84M |
Net income from continuing operations | 0.10%-4.89M | 103.81%285K | -5.06%-6.38M | -31.38%-20.79M | 47.09%-2.35M | -3,090.80%-4.89M | -10.43%-7.47M | -27.04%-6.07M | 20.88%-15.82M | 0.96%-4.44M |
Operating gains losses | 205.19%81K | ---- | ---- | -3.25%-297.31K | 14.19%-250.31K | -8,465.07%-77K | ---51K | --81K | -110.27%-287.95K | -228.41%-291.7K |
Depreciation and amortization | 87.77%5.34M | 158.55%5.82M | 69.00%3.87M | 93.57%10.47M | 78.20%3.08M | 71.17%2.85M | 115.87%2.25M | 135.20%2.29M | 354.80%5.41M | 386.26%1.73M |
Asset impairment expenditure | --0 | ---2K | 2,094.44%359K | -97.31%5.92K | -100.07%-85 | -44.87%24K | --0 | ---18K | --219.76K | --124.87K |
Remuneration paid in stock | -31.11%392K | -12.66%531K | -31.54%343K | 77.78%2.47M | 33.13%787.04K | 716.18%569K | 77.26%608K | 30.94%501K | 10.53%1.39M | -14.14%591.2K |
Other non cashItems | 45.00%1.07M | 134.62%915K | 35.86%466K | -62.25%1.34M | -104.31%-135.78K | --740K | --390K | --343K | --3.54M | --3.15M |
Change In working capital | 68.50%-3.02M | -178.47%-6.73M | -136.39%-793K | 178.00%5.43M | 256.82%4.24M | -551.16%-9.58M | 32,825.38%8.58M | -13.23%2.18M | -48.22%1.95M | -414.17%-2.71M |
-Change in receivables | 103.79%74K | 45.76%-909K | 438.49%4.25M | -297.92%-7.75M | -150.15%-2.86M | -520.80%-1.96M | -119.29%-1.68M | -554.79%-1.26M | -161.08%-1.95M | -65.74%-1.14M |
-Change in prepaid assets | 18.71%-404K | 306.22%1.16M | -417.36%-626K | 74.50%-321.84K | 1,346.27%859.16K | 34.41%-497K | -304.14%-563K | 85.59%-121K | 60.20%-1.26M | 102.13%59.41K |
-Change in payables and accrued expense | 140.44%1.99M | -118.99%-2.27M | -120.36%-1.05M | 110.06%19.52M | 14,084.78%7.32M | -212.51%-4.91M | 920.47%11.95M | 35.62%5.16M | 16.12%9.29M | -101.23%-52.34K |
-Change in other current assets | -122.62%-57K | -167.64%-301K | -98.83%3K | 589.12%1.67M | 309.28%712.74K | --252K | --445K | --256K | ---340.56K | ---340.56K |
-Change in other current liabilities | -87.41%-4.62M | -180.74%-4.42M | -80.73%-3.37M | -102.85%-7.69M | -45.28%-1.79M | -110.25%-2.46M | -139.64%-1.57M | -154.75%-1.86M | -1,111.04%-3.79M | -1,694.40%-1.23M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 90.19%-1.02M | -79.25%894K | -206.61%-2.13M | 61.69%-1.38M | 392.01%5.38M | -333.02%-10.37M | 181.34%4.31M | 23.68%-696K | 66.65%-3.6M | 21.65%-1.84M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 72.26%-1.04M | 32.13%-1.97M | -187.00%-3.25M | -155.61%-13.19M | -691.35%-5.41M | -117.23%-3.74M | -56.11%-2.91M | -26.95%-1.13M | -690.30%-5.16M | -154.74%-683.13K |
Net PPE purchase and sale | -257.27%-1.4M | 29.15%-1.89M | -459.28%-1.72M | -111.45%-4.04M | -149.10%-1.96M | 439.93%887K | -350.62%-2.66M | -12.44%-307K | -192.86%-1.91M | -436.32%-786.96K |
Net other investing changes | 107.71%357K | 64.49%-87K | -85.56%-1.53M | -181.60%-9.14M | -3,418.49%-3.45M | -216.70%-4.63M | 80.73%-245K | -33.37%-824K | ---3.25M | --103.83K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 72.26%-1.04M | 32.13%-1.97M | -187.00%-3.25M | -155.61%-13.19M | -691.35%-5.41M | -117.23%-3.74M | -56.11%-2.91M | -26.95%-1.13M | -690.30%-5.16M | -154.74%-683.13K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -102.48%-569K | -165.52%-539K | -106.43%-231K | 330.08%26.78M | 131.18%405.96K | 7,257.20%22.98M | -132.00%-203K | -37.38%3.59M | -67.10%6.23M | -15.35%175.6K |
Net issuance payments of debt | -102.48%-569K | -5.73%-627K | -109.67%-231K | 359.19%24.91M | 171.20%128.18K | 7,257.00%22.98M | ---593K | -59.68%2.39M | --5.42M | ---180.03K |
Net common stock issuance | --0 | -51.79%188K | --0 | 133.29%1.87M | 75.73%277.78K | --0 | -38.52%390K | 12,024.87%1.2M | -95.78%802.33K | -57.54%158.07K |
Cash dividends paid | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.49%-1K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -102.48%-569K | -166.83%-539K | -106.43%-231K | 330.08%26.78M | 131.18%405.96K | 7,257.20%22.98M | -131.85%-202K | -37.40%3.59M | -67.05%6.23M | -15.35%175.6K |
Net cash flow | ||||||||||
Beginning cash position | 23.99%10.45M | 66.93%12.06M | 223.66%17.68M | -31.69%5.46M | 121.51%17.3M | 55.94%8.43M | -39.42%7.23M | -31.69%5.46M | 1,356.92%7.99M | -12.14%7.81M |
Current changes in cash | -129.57%-2.62M | -234.95%-1.62M | -417.72%-5.61M | 582.19%12.21M | 116.02%376.3K | 268.76%8.87M | 118.37%1.2M | -55.12%1.77M | -134.02%-2.53M | -162.54%-2.35M |
End cash Position | -54.78%7.82M | 23.99%10.45M | 66.93%12.06M | 223.67%17.68M | 223.67%17.68M | 121.51%17.3M | 55.94%8.43M | -39.42%7.23M | -31.69%5.46M | -31.69%5.46M |
Free cash from | 74.56%-2.41M | -160.23%-992K | -283.95%-3.85M | 1.65%-5.42M | 229.98%3.42M | -326.36%-9.48M | 127.97%1.65M | 15.36%-1M | 51.86%-5.51M | -5.26%-2.63M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.